Related Experiment Videos
Expression of sex hormone-binding globulin mRNA in uterine cervical cancers
R Misao1, Y Nakanishi, J Fujimoto
1Department of Obstetrics and Gynecology, Gifu University School of Medicine, Japan.
Abstract:
To explore the role of sex hormone-binding globulin (SHBG) in the intracellular steroidal actions in human uterine cervical cancers, the expression of SHBG mRNA as a manifestation of intracellular SHBG expression was investigated using the competitive reverse transcription-polymerase chain reaction-Southern blot analysis. The expression of SHBG mRNA was detected in all cervical endometria and cancers analyzed. The levels of SHBG mRNA in cervical cancers were significantly lower (p < 0.01) than in the normal cervical endometrium. In cervical cancers, the levels of SHBG mRNA in cervical adenocarcinomas were significantly higher (p < 0.01) than in keratinizing and small cell nonkeratinizing squamous cell carcinomas, and tended to be higher than in large cell nonkeratinizing squamous cell carcinomas. There was no difference in expression among the clinical stages of cervical cancers. These data suggest that human uterine cervical cancers, especially adenocarcinomas, might synthesize SHBG intracellularly, and might conserve the activity of SHBG-related steroidal mechanisms to some extent.
Insights
Sex hormone-binding globulin (SHBG) mRNA levels are lower in cervical cancers than normal tissue. Adenocarcinomas show higher SHBG mRNA than squamous cell types, suggesting intracellular SHBG synthesis in these cancers.
Area of Science:
- Gynecology
- Endocrinology
- Molecular Biology
Background:
- Sex hormone-binding globulin (SHBG) plays a role in steroid hormone transport and action.
- Intracellular functions of SHBG in gynecological cancers are not fully understood.
- Investigating SHBG expression provides insights into steroid-mediated mechanisms in cervical cancer.
Purpose of the Study:
- To investigate the expression of SHBG mRNA in human uterine cervical cancers.
- To explore the potential role of intracellular SHBG in steroidal actions within cervical cancer cells.
- To compare SHBG mRNA levels between normal cervical tissue and various types of cervical cancer.
Main Methods:
- Competitive reverse transcription-polymerase chain reaction-Southern blot analysis was used to quantify SHBG mRNA levels.
- Samples included normal cervical endometrium and various cervical cancer subtypes (adenocarcinoma, squamous cell carcinoma).
- SHBG mRNA expression was analyzed across different clinical stages of cervical cancer.
Main Results:
- SHBG mRNA was detected in all analyzed cervical tissues, both normal and cancerous.
- Cervical cancers exhibited significantly lower SHBG mRNA levels compared to normal cervical endometrium (p < 0.01).
- Cervical adenocarcinomas showed significantly higher SHBG mRNA levels than keratinizing and small cell nonkeratinizing squamous cell carcinomas (p < 0.01).
Conclusions:
- Human uterine cervical cancers, particularly adenocarcinomas, may synthesize SHBG intracellularly.
- These cancers might retain some activity of SHBG-related steroidal mechanisms.
- Further research is warranted to elucidate the precise role of intracellular SHBG in cervical cancer progression.